baber/WOPTO huggingface dataset:
Patent EP-3996065-A1 (EP)
Title: System and method for parking tracking using vehicle event data
Inventor: DOWNING ROGER
IPC: G08G1/14
Filed: 2021-11-10
Abstract: A system and method is provided for determining where a vehicle has parked in a parking lot. The method includes determining a geometry for a parking lot; receiving vehicle event data including periodic vehicle event data for vehicle speed and steering angle; tracking a movement of a vehicle using the vehicle event data; and determining where a vehicle has parked using a steering angle to determine a number of turns in the parking lot geometry.
Patent EP-4156373-A1 (EP)
Title: Battery and battery apparatus
Inventor: DONG YIFAN
IPC: H01M50/583
Filed: 2021-11-15
Abstract: A battery and a battery apparatus are provided. The battery includes a housing (10), a positive current collector (20), a negative current collector (30) and a resistor assembly (40). The positive and negative current collectors (20, 30) are disposed at the housing (10). The positive current collector (20) is electrically connected to the housing (10) through the resistor assembly (40). The resistor assembly (40) includes a first resistor (41) and a second resistor (42) arranged in parallel. A resistance value of the first resistor (41) is greater than a resistance value of the second resistor (42). By arranging the first and second resistors (41, 42) in parallel and configuring the resistance value of the first resistor (41) to be greater than that of the second resistor (42), a total resistance value of the first and second resistors (41, 42) is less than the resistance value of the second resistor (42).
Patent EP-4011858-A1 (EP)
Inventor: BABA AKIHIRO
IPC: C07C67/08
Filed: 2021-12-07
Abstract: The present invention relates to a process for preparing a 3-isopropenyl-6-heptenal compound of the following formula (2): wherein R<sup>1</sup> represents a hydrogen atom or a methyl group, the process comprising: subjecting a 3-isopropenyl-6-heptenoate ester compound of the following formula (1): wherein R<sup>1</sup> is as defined above, and R<sup>2</sup> represents a monovalent hydrocarbon group having 1 to 10 carbon atoms, to a reduction reaction with a reducing agent to form the 3-isopropenyl-6-heptenal compound (2).
Patent EP-4015006-A1 (EP)
Title: Conveyer belt type plasma sterilizer
Inventor: LEE CHANG HOON
IPC: B65G41/00
Filed: 2021-12-10
Abstract: A conveyer belt type plasma sterilizer is provided, including a first chamber having a shape of a square cylinder with a closed ceiling and an open bottom, the first chamber including a plurality of first plasma ejection tools on one sidewall, a second chamber having a shape of a square cylinder, in which the second chamber is formed to be longer than the first chamber to surround the first chamber when viewed along a longitudinal direction of the first chamber, and includes a plurality of gas inlet holes below the first chamber and a plurality of gas outlet holes on the ceiling of the first chamber, a first conveyer belt at one side of the second chamber, extending from an outside of the second chamber to a vicinity of the second chamber, a second conveyer belt starting near the first conveyer belt, extending through the second chamber and the first chamber, and toward the other side of the second chamber, and a plurality of second plasma ejection tools below the second chamber, facing each of the gas inlet holes of the second chamber.
Patent EP-4194908-A1 (EP)
Inventor: TIMMERMANS ROGER ANTON MARIE
IPC: G21K1/00
Filed: 2021-12-10
Abstract: An aperture for detecting a laser beam misalignment, the aperture comprising: a body including a first opening and defining a first axis; a beam dump; an optical element including a second opening wherein the first opening and the second opening are coaxial with the first axis, the optical element being configured to redirect a misaligned laser beam to a detector or to split a misaligned laser beam into at least two sub-beams; a laser beam detection system configured to detect laser light, wherein the optical element is configured to direct a first sub-beam to the beam dump, and to direct a second sub-beam to the laser beam detection system. Also described is an aperture including an enclosure, a method of detecting misalignment of a laser beam, a radiation source comprising such an aperture, a lithographic apparatus comprising such a radiation source or aperture, and the use of the same in a lithographic apparatus or method.
Patent EP-4036777-A1 (EP)
Inventor: NIKOLA DANIEL
IPC: G06F21/62
Filed: 2021-12-15
Abstract: Die Erfindung betrifft ein Verfahren und eine Vorrichtung zur Erhebung wenigstens eines Bildes unter Wahrung der Anonymität einer jeweils erfassten Person.Die Aufgabe, die der Erfindung zu Grunde liegt, ist den datenschutzrechtlichen Anforderungen der DS-GVO in Europa bei der Erhebung von Bildern mit personenbezogenen Daten gerecht zu werden.Dies gelingt der Erfindung dadurch, dass jeder von der optischen Einrichtung aller erzeugten Pixel durch die Verfremdungseinheit vor der Erstellung des Bildes derart verfremdet, dass aus dem mittels der verfremdeten Pixel erstellbaren Bildes nur noch Informationen auslesbar sind, die jeweils nicht einer konkreten Person zugeordnet werden können. Mit anderen Worten: Mit der Erfindung besteht nicht die Möglichkeit personenbezogene Daten von vornherein erkennbar zu erfassen.
Patent EP-3978000-A1 (EP)
Inventor: VLCEK RADIM
IPC: A61P31/14
Filed: 2021-09-30
Abstract: Gegenstand der Erfindung ist der Einsatz von Desoxycholsäure sowie deren Verbindungen zur Verwendung bei der Behandlung von Erkrankungen mit Corona-Viren (CoV).Coronaviren lösen grippeähnliche Atemwegserkrankungen aus. Speziell das SARS-CoV-2 hat sich zu einer weltweiten Pandemie ausgebreitet. Bis zum heutigen Zeitpunkt besteht keine etablierte therapeutische Behandlungsmöglichkeit einer Virämie mit einem Coronavirus - man ist auf Impfungen und Hygienemaßnahmen angewiesen.Die Aufgabe der Erfindung besteht in der Hebung der Wirkkraft des unspezifischen Immunsystems zu Beginn einer CoV-Erkrankung (etwa Tag 1.-4.). Dadurch soll auf einen milderen sowie verkürzten Krankheitsverlauf hingewirkt werden.Als Wirkstoff einer Formulierung zur Behandlung einer CoV-Erkrankung wird die freie Desoxycholsäure (C<sub>24</sub>H<sub>40</sub>O<sub>4</sub>, CAS: 83-44-3) in pharmazeutisch wirksamer Menge eingesetzt, oder deren zielführende Verbindungen. Desoxycholsäure besitzt die Fähigkeit zur Stimulierung des unspezifischen Immunsystems, darunter auch der Makrophagen.Die erfindungsgemäße Anwendung von Desoxycholsäure in der ersten Phase einer CoV-Erkrankung erschließt die Möglichkeit, die aufkeimende Virämie vor der Phase der pulmonalen Manifestation zu behandeln. Gelingt hier eine effektive Intervention, wird der Krankheitsverlauf gemildert und die Anzahl der schweren Erkrankungsfälle gesenkt. Infolgedessen wird die Liegezeit der Erkrankten verkürzt, was für den Patienten, die Gesundheitssysteme sowie Volkswirtschaften entscheidend positive Folgen hätte.
Patent EP-4090464-A1 (EP)
Inventor: OZTURK SEDIDE
IPC: B01L3/00
Filed: 2021-01-15
Abstract: Described herein are systems and methods for randomly dividing a population of particles into two or more sub-populations, reacting each formed sub-population of particles with a different reagent, pooling the reacted sub-populations of particles back together.
Patent EP-4121213-A1 (EP)
Title: Zyklonabscheider
Inventor: TRALMER TOBIAS
IPC: B04C5/13
Filed: 2021-02-22
Abstract: Die Erfindung betrifft einen Zyklonabscheider, umfassend einen Basiskörper (2) mit einer Zuleitung (20), einer Ableitung (21) und einer Ausnehmung (23), welche als Sackloch ausgebildet ist und zu einer Bodenseite des Basiskörpers (2) geöffnet ist, wobei die Zuleitung (20) seitlich an einem Wandbereich (24) der Ausnehmung (23) mündet und die Ableitung (21) von einer Grundfläche (25) der Ausnehmung (23) zu einem seitlichen Auslass (210) am Basiskörper (2) führt, einen Innenkonus (3) mit einem Hohlraum (30), wobei der Innenkonus (3) in der Ausnehmung (23) angeordnet ist, und eine Bodenplatte (4), welche die Ausnehmung (23) am Basiskörper (2) verschließt, wobei die Bodenplatte (4) einen Schmutzmedienanschluss (5) aufweist.
Patent EP-4100478-A1 (EP)
Title: Coating composition
Inventor: POLAND MARK
IPC: C09D127/12
Filed: 2021-02-05
Abstract: The present disclosure relates to a coating composition, comprising a fluoropolymer component in the form of a fluoropolymer micropowder having a weight average molecular weight of from 300,000 g/mol to 400,000 g/mol, a binder resin, a hydroxy-functional silicone resin; and a silicone oil, as well as articles coated with the composition.
Patent EP-4104395-A1 (EP)
Inventor: COLENBRANDER ROELOF RODERICK
IPC: H05K7/14
Filed: 2021-02-13
Abstract: A network architecture including a streaming array that includes a plurality of compute sleds, wherein each compute sled includes one or more compute nodes. The network architecture including a network storage of the streaming array. The network architecture including a PCIe fabric of the streaming array configured to provide direct access to the network storage from a plurality of compute nodes of the streaming array. The PCIe fabric including one or more array-level PCIe switches, wherein each array-level PCIe switch is communicatively coupled to corresponding compute nodes of corresponding compute sleds and communicatively coupled to the network storage. The network storage is shared by the plurality of compute nodes of the streaming array.
Patent EP-4110087-A1 (EP)
Inventor: LÓPEZ PEDROSA JOSÉ MARÍA
IPC: A61K31/7016
Filed: 2021-02-26
Abstract: A method of promoting bone health in a moderately malnourished individual is provided. The method includes treating the moderately malnourished individual with a nutritional composition that contains a carbohydrate blend. The carbohydrate blend includes a source of at least one carbohydrate that provides rapidly available glucose, a source of at least one carbohydrate that provides slowly available glucose, and a source of at least one non-digestible carbohydrate or resistant starch.
Patent EP-4125486-A1 (EP)
Inventor: MURPHY-REINHERTZ NOAH
IPC: A43C11/00
Filed: 2021-02-22
Abstract: La présente invention concerne des systèmes de laçage pour des articles d'habillement pouvant comprendre un premier élément de lacet continu et un second élément de lacet continu, ayant chacun une partie de réception de lacet fixée à l'article d'habillement, directement ou indirectement, et une partie de laçage pouvant venir en prise avec des ouvertures de boucle respectives de la partie de réception de lacet pour fournir un mécanisme de fermeture. Les articles d'habillement peuvent être des articles chaussants et le système de laçage peut être prévu pour fermer une ouverture dans une partie supérieure de l'article chaussant.
Patent EP-4136080-A1 (EP)
Inventor: BURTON PAUL MATTHEW
IPC: A01N43/713
Filed: 2021-04-12
Abstract: The present invention related to compounds of Formula (I) or an agronomically acceptable salt thereof, wherein Q, R 2 , R 3 , R 4  and R 5  are as described herein. The invention further relates to compositions comprising said compounds, to methods of controlling weeds using said compositions, and to the use of Compounds of Formula (I) as a herbicide.
Patent EP-4117492-A1 (EP)
Inventor: STEDRONSKY ERWIN
IPC: A47J36/32
Filed: 2021-03-12
Abstract: Method for dispensing a recipe includes measuring characterization data for components of a recipe. A signal representing an instruction to dispense the recipe is received at a processor operably coupled to a dispenser. In response to receiving the signal representing the instruction to dispense, an instruction set is generated based on the recipe and the characterization data. The instruction set is executed, to cause a series of delivery events of the components. Prior to each individual delivery event comprising the instruction set, a deviation, from their predetermined setpoints, is detected in a temperature and/or a pressure of the microfluidic dispenser. In response to detecting the deviation in temperature and/or pressure, the processor automatically causes an adjustment to one or more instructions from the instruction set based on the detected variation such that the amount of each component delivered more closely conforms to the amount specified in the recipe.
Patent EP-4125842-A1 (EP)
Title: Co-administration of mirdametinib and lifirafenib for use in treating cancers
Inventor: LUO LUSONG
IPC: A61K9/00
Filed: 2021-04-02
Abstract: The present disclosure relates to methods of treating cancers comprising coadministration of mirdametinib or a pharmaceutically acceptable salt form thereof, and lifirafenib or a pharmaceutically acceptable salt form thereof, to a patient in need thereof. Also disclosed are pharmaceutical compositions of mirdametinib or a pharmaceutically acceptable salt form thereof, and lifirafenib or a pharmaceutically acceptable salt form thereof, for use in such cancer treatment, as well as uses of these compounds for manufacture of medicaments for the treatment of cancers.
Patent EP-4169334-A1 (EP)
Inventor: WANG MIN
IPC: H04L5/00
Filed: 2021-05-14
Abstract: Des procédés, une station de base et un équipement terminal sont divulgués pour une transmission de liaison montante. Selon un mode de réalisation, la station de base envoie, à un équipement terminal desservi par la station de base, une signalisation comprenant un ou plusieurs octrois de liaison montante. La signalisation indique ou implique le service ou les services qui sont autorisés à utiliser le ou les octrois de liaison montante.
Patent EP-4169014-A1 (EP)
Title: Spontaneous text to speech (tts) synthesis
Inventor: ZHANG RAN
IPC: G10L13/10
Filed: 2021-04-22
Abstract: The present disclosure provides methods and apparatuses for spontaneous text-to-speech (TTS) synthesis. A target text may be obtained. A fluency reference factor may be determined based at least on the target text. An acoustic feature corresponding to the target text may be generated with the fluency reference factor. A speech waveform corresponding to the target text may be generated based on the acoustic feature.
Patent EP-4143843-A1 (EP)
Inventor: TSADOK YOSSI
IPC: G16H30/40
Filed: 2021-04-27
Abstract: A system for selecting images of an event indicator includes a processor and a memory storing instructions which, when executed, cause the system to: access images of a portion of a gastrointestinal tract captured by a capsule endoscopy device; for each of the images, access one or more scores indicating a presence of an event indicator; select seed images from among the images based on the one or more scores; deduplicate the seed images for images showing the same occurrence of the event indicator, where the deduplicating utilizes a consecutive-image tracker; and present the deduplicated seed images in a graphical user interface to display potential occurrences of the event indicator.
Patent EP-4256489-A1 (EP)
Title: Method and system for dynamically recommending commands for performing a product data management operation
Inventor: DAVE MANAL
IPC: G06Q10/00
Filed: 2021-04-28
Abstract: A method and system for dynamically recommending commands for performing a PDM operation on product data objects in a product data management environment is disclosed. In one embodiment, a method includes determining a context in which a user is operating within a product data management environment. The method includes dynamically determining a set of commands suitable for performing a candidate PDM operation on the product data objects based on the determined context. Furthermore, the method includes computing a score for each of the commands suitable for performing the candidate PDM operation on the product data objects. Moreover, the method includes assigning a rank to said each command suitable for performing the candidate PDM operation based on the score associated with said each command, and outputting one or more commands from the set of commands on a graphical user interface based on the rank assigned to said each command.
Patent EP-4161327-A1 (EP)
Inventor: RUTTEN MATHIAS ANTHONIUS FRANCISCUS
IPC: A47J31/44
Filed: 2021-06-01
Abstract: A coffee machine (1) comprising a frother (2) with an outlet channel (3) for coffee and milk foam, and supply channels (5, 6, 7) for milk, air, and steam respectively, and provided with a nonreturn valve (15) to prevent a fluid in one of the channels from flowing in an undesirable direction, wherein the coffee machine (1) is further provided with a clean water supply channel (8) that connects to the milk supply channel (5) with a T-junction (9) distant from the frother (2), wherein the T-junction (9) further connects to a source channel (11) for the milk.
Patent EP-4176520-A1 (EP)
Inventor: HAKOLA SAMI
IPC: H04B7/08
Filed: 2021-06-14
Abstract: An apparatus comprising: at least one processor; and at least one memory including computer program code; the at least one memory and the computer program code configured to, with the at least one processor, cause the apparatus at least to: maintain (906) a measurement report pool comprising a plurality of measurement reports provided to a base station, each measurement report indicating one or more downlink reference signals; receive (908) information indicating a selected measurement report within the measurement report pool and indicating a selected downlink reference signal within the selected measurement report from a base station; and determine (910) a serving beam based on the selected downlink reference signal within the selected measurement report.
Patent EP-4146635-A1 (EP)
Inventor: BOWLIN STEPHEN URIAH
IPC: C07D253/08
Filed: 2021-05-06
Abstract: La présente invention concerne des composés qui sont des métabolites mammifères d'un agoniste du récepteur 1.39 couplé à la protéine G (GPR139), des intermédiaires utilisés dans la synthèse de tels métabolites, des compositions pharmaceutiques comprenant de tels métabolites, et l'utilisation de tels métabolites en tant que biomarqueurs et agents dans le traitement de la schizophrénie, par exemple, des symptômes négatifs et/ou cognitifs de la schizophrénie, des troubles associés à un dysfonctionnement social et cognitif, ainsi que plusieurs autres troubles liés à une modulation de GPR139.
Patent EP-4161570-A1 (EP)
Inventor: BIANCUCCI MARCO
IPC: A61K39/215
Filed: 2021-06-04
Abstract: Betacoronavirus Spike proteins, or fragments thereof, including substitution mutations designed to increase stability, decrease the risk of antibody dependent enhancement, or both; and that are useful in, for example, immunogenic compositions.
Patent EP-4089203-A1 (EP)
Title: Method for producing fluorine-containing organic compound
Inventor: INAGI SHINSUKE
IPC: C25B3/28
Filed: 2021-01-08
Abstract: An object of the present disclosure is to provide a novel method for producing a fluorine-containing organic compound by electrolytic fluorination, and the like. The object can be achieved by a method for producing a fluorine-containing organic compound (1), comprising step A of subjecting an organic compound (2) to electrolytic fluorination in the presence of 0.2 M or more of a metal fluoride, and a fluoroalcohol.
Patent EP-4182636-A1 (EP)
Title: Apparatus for detecting sensor error
Inventor: COSGROVE GAVIN PATRICK
IPC: G01D5/244
Filed: 2021-07-08
Abstract: A magnetic angle measurement system having magnetic angle sensors, signal processing circuitry and a processor is disclosed. First signal processing circuitry receives a first subset of outputs of a first plurality of outputs from a first magnetic angle sensor and determines first magnetic angle data based on the received first subset of outputs. Second signal processing circuitry receives a second subset of the outputs from the first magnetic angle sensor and determines second magnetic angle data based on the received second subset of outputs. Third signal processing circuitry receives a second plurality of outputs from the second magnetic sensor and determines third magnetic angle data based on the received second plurality of outputs. The processor compares the magnetic angle data and determines a processing result based on the comparison, where fault tolerance resolution of the magnetic angle measurement system is based at least in part on the processing result.
Patent EP-4095140-A1 (EP)
Inventor: KIM JONG WOO
IPC: C07D487/04
Filed: 2021-01-22
Abstract: The present inventors have arrived at the present application by confirming that a novel quinazoline derivative exhibits therapeutic efficacy for metabolic disorders. The quinazoline derivative according to the present application has a similar structure to that of idelalisib, but exhibits very different properties and a different mechanism of action from idelalisib. In addition, this derivative molecule was shown to have excellent efficacy against metabolic disorders, in particular lipid metabolic disorders, through different mechanism of action. The derivative molecule also showed excellent efficacy against non-alcoholic steatohepatitis (NASH). No non-alcoholic steatohepatitis treatment drugs have been approved at the time of filing.
Patent EP-4186214-A1 (EP)
Inventor: Zhao wen ji
IPC: H04L61/00
Filed: 2021-06-29
Abstract: A network device having an embedded router (eRouter) providing connections for a plurality of client devices in a local area network, and an embedded cable modem (eCM) bridging communication between a wide area network (WAN) network and the eRouter. The network device also includes a memory, and at least one processor configured to execute instructions stored on said memory to cause said network device to implement an eRouter physical interface and an eCM physical interface according to a configuration file;, and to transmit a generic routing encapsulation (GRE) domain name system (DNS) query to a DNS server from the eRouter physical interface or the eCM physical interface.
Patent EP-4101924-A1 (EP)
Inventor: ANDO MIKI
IPC: C12N5/0783
Filed: 2021-02-05
Abstract: Provided are cytotoxic T cells derived from human T cell-derived iPS cells that can avoid an NK cell missing-self response and that can be used for allogeneic administration while maintaining a strong antitumor effect of antigen-specific CTLs, and a method for producing the same.A method for producing a cytotoxic T cell derived from a human T cell-derived iPS cell expressing HLA class I of HLA-restricted class I of an antigen epitope of a CTL and HLA-E, the method including: a step of knocking out all HLA class I of the human T cell-derived iPS cell; a step of introducing a gene of the HLA-restricted HLA class I of the antigen epitope of the CTL and a gene of the HLA-E into the T-iPS cell in which all HLA class I have been knocked out; and a step of redifferentiating the genetically introduced T-iPS cell into a CD8 single-positive T cell.
Patent EP-4193505-A1 (EP)
Title: Netzwerk zur datenübertragung
Inventor: HELLMANN KLAS
IPC: H04L/
Filed: 2021-08-02
Abstract: Die Erfindung betrifft ein Netzwerk zur Datenübertragung, insbesondere in der Automatisierungstechnik, mit mehreren Endgeräten (1-4), einem gemeinsamen Gateway (5) zur externen Anbindung des Netzwerks an ein externes Datenübertragungsnetz (6), Datenverbindungen (Linkl-Link4) zwischen dem Gateway (5) und den Endgeräten (1-4), sowie mit mehreren OPC-UA-Servern (8-11), wobei den einzelnen Endgeräten (1-4) jeweils einer der OPC-UA- Server (8-11) zugeordnet ist. Die Erfindung sieht vor, dass in den einzelnen Endgeräten (1-4) jeweils eine Softwarekomponente (12) gespeichert ist, die geeignet ist, um einen der OPC-UA-Server (8-11) zu bilden. Weiterhin sieht die Erfindung vor, dass das Gateway (5) die Softwarekomponenten (12) für die Bildung der einzelnen OPC-UA- 20 Server (8-11) von den Endgeräten (1-4) lädt und in dem Gateway (5) ausführt.